DISEASES AND PROBLEMS DISTINGUISHED BY WHO AND FAO / REVIEW PAPER
Viral hemorrhagic fevers - a recurrent public health threat
More details
Hide details
1
Pope John Paul II State School of Higher Education in Biała Podlaska, Poland
2
The Provincial Specialist Hospital in Biała Podlaska, Poland
Submission date: 2021-09-30
Final revision date: 2021-10-05
Acceptance date: 2021-10-06
Publication date: 2021-12-15
Health Prob Civil. 2021;15(4):255-269
KEYWORDS
TOPICS
ABSTRACT
Viral hemorrhagic fevers (VHFs) caused by viruses are severe infectious diseases that lead to serious disturbances of the body’s homeostasis, in most cases accompanied by symptoms of hemorrhagic diathesis. They are spread by infection vectors such as insects (mosquitoes, ticks), airborne droplets or direct contact with contaminated material (blood, sweat, excrement, feces). There are four major groups of RNA viruses that cause hemorrhagic fevers – these include pathogens from the families Flaviviridae, Bunyaviridae, Arenaviridae and Filoviridae. Despite their common name, VHFs are distinct disease entities with different etiologies, clinical manifestations and routes of transmission. Although they have been known for several decades and are associated with illnesses in tropical countries, the risk of their occurrence, in times of globalization and widespread international travel, is increasingly high. It is not insignificant that progressive climate change is making vectors of VHFs, which years ago were seen only in tropical countries, increasingly common on the European continent and even in eastern European countries.
REFERENCES (46)
1.
Korzeniewski K. [Viral haemorrhagic fevers]. Forum Medycyny Rodzinnej. 2012; 6(5): 205-221 (in Polish).
2.
Korzeniewski K. [Viral hemorrhagic fevers – selected clinical problems]. Gdynia: Via Medica; 2012 (in Polish).
3.
Zieliński A, Rosińska M, Gut W. [Hemorrhagic fevers – epidemiology and clinics]. Przegląd Epidemiologiczny. 2003; 57: 639-54 (in Polish).
4.
www.cdc.gov/ncidod/diseases [Internet]. Atlanta: Centers for Disease Control and Prevention. National Center for Infectious Diseases, Special Pathogens Branch [cited 2017 Dec 12]. Available from: www.cdc.gov/ ncidod/diseases.
6.
McCormack J, Sorrell T, Johnson P, Yung A, Spelman D, Street A. Infectious diseases: a clinical approach. Melbourne: IP Communications; 2014.
7.
Moreno ES, Agostini I, Holzmann I, Di Bitetti MS, Oklander LI, Kowalewski MM, et al. Yellow fever impact on brown howler monkeys (Alouatta guariba clamitans) in Argentina: a metamodelling approach based on population viability analysis and epidemiological dynamics. Mem. Inst. Oswaldo Cruz. 2015; 110: 865-876.
https://doi.org/10.1590/0074-0....
8.
Fernandes NC, Cunha MS, Guerra JM, Réssio RA, Cirqueira CdS, Iglezias SDA, et al. Outbreak of yellow fever among Nonhuman primates. Espirito Santo, Brazil, 2017. Emerg. Infect. Dis. 2017; 23: 2038-2041.
https://doi.org/10.3201/eid231....
9.
Auguste AJ, Lemey P, Bergren NA, Giambalvo D, Moncada M, Morón D, et al. Enzootic transmission of yellow fever virus, Venezuela. Emerg. Infect. Dis. 2015; 21: 99-102.
https://doi.org/10.3201/eid210....
10.
Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, et al. Hemorrhagic fever viruses as biological weapons. Medical and public health menagement (consensus statement). JAMA. 2002; 287(18): 2391-404.
https://doi.org/10.1001/jama.2....
11.
Wilder-Smith A. Viral hemorrhagic fevers. In: Schwartz E., editor. Tropical diseases in travelers. Oxford: Wiley-Blackwell; 2009. 243-253.
12.
Wu W, Ren H, Lu L. Increasingly expanded future risk of dengue fever in the Pearl River Delta, China. PLoS Negl Trop Dis. 2021; 15(9): e0009745.
https://doi.org/10.1371/journa....
13.
Hussain-Alkhateeb L, Rivera Ramírez T, Kroeger A, Gozzer E, Runge-Ranzinger S. Early warning systems (EWSs) for chikungunya, dengue, malaria, yellow fever, and Zika outbreaks: what is the evidence? A scoping review. PLoS Negl Trop Dis. 2021; 15(9): e0009686.
https://doi.org/10.1371/journa....
14.
Nimmannitya S. Dengue and dengue hemorrhagic fever. In: Cook GC, Zumla AI., editors. Manson’s tropical diseases. 22nd edition. London: Saunders Elsevier; 2009. p. 753-760.
https://doi.org/10.1016/B978-1...- 4470-3.50045-8.
15.
Halstead SB, Lan N, Myint T, Shwe TN, Nisalak A, Kalyanarooj S, et al. Dengue hemorrhagic fever in infants: research opportunities ignored. EID. 2002; 8(12): 1474-1479.
https://doi.org/10.3201/eid081....
16.
Wang WK, Chao DY, Kao CL, Han-Chung W, Yung-Ching L, Chien-Ming L, et al. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology. 2003; 305(2): 330-88.
https://doi.org/10.1006/viro.2....
17.
Yeh TM, Liu H, Lin YS, Yee-Shin Lin, Shun-Hua C, Ching-Chuan L, et al. Immunopathogenesis of dengue virus infection. J Biomed Sci. 2001; 8(5): 377-388.
https://doi.org/10.1007/BF0225....
18.
Mairuhu AT, Mac Gillavry MR, Setiati TE, Soemantri A, H ten C, Brandjes DPM, et al. Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect Dis. 2003; 3(1): 33-41.
https://doi.org/10.1016/S1473-....
19.
Chiou-Feng L, Huan-Yao L, Ai-Li S, Ching-Chuan L, Hsiao-Sheng L, Trai-Ming Y, et al. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med. Virol. 2003; 69(1): 82-90.
https://doi.org/10.1002/jmv.10....
20.
Clark MB, Schaefer TJ. West Nile virus. Treasure Island (FL): StatPearls Publishing; 2021.
21.
Nelson KE. Emerging vector-borne infections. In: Nelson KE, Williams CM., editors. Infectious disease epidemiology: theory and practice. 2nd edition. Sudbury, Massachusetts: Jones and Bartlett Publishers; 2007. p. 1023-1057.
22.
Karan LS, Ciccozzi M, Yakimenko VV, Lo Presti A, Cella E, Zehender G, et al. The deduced evolution history of Omsk hemorrhagic fever virus. J Med Virol. 2014; 86(7): 1181-1187.
https://doi.org/10.1002/jmv.23....
23.
Morse LJ. Modes of transmission of hemorrhagic fevers. JAMA. 2002; 288: 571. 24. Gupta N, Wilson W, Neumayr A, Saravu K. Kyasanur forest disease: state-of-the-art review. QJM. 2020; Nov 16: hcaa310.
https://doi.org/10.1093/qjmed/....
25.
Parvi K. Clinical, clinicopathologic and hematologic features of Kyasanur forest disease. Rev Infect Dis. 1989; 11(Suppl. 4): S854-9.
https://doi.org/10.1093/clinid....
26.
Fanelli A, Buonavoglia D. Risk of Crimean Congo haemorrhagic fever virus (CCHFV) introduction and spread in CCHF-free countries in southern and Western Europe: a semi-quantitative risk assessment. One Health. 2021; 13: 100290.
https://doi.org/10.1016/j.oneh....
27.
Jonkmans N, D’Acremont V, Flahault A. Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases. BMJ Glob Health. 2021; 6(9): e006623.
https://doi.org/10.1136/bmjgh-....
28.
Jaureguiberry S, Tattevin P, Tarantola A, Legay F, Tall A, Nabeth P, et al. Imported Crimean-Congo hemorrhagic fever. J. Clin. Microbiol. 2005; 43: 4905-4907.
https://doi.org/10.1128/JCM.43....
29.
Khan AS, Maupin GO, Rollin PE, Noor AM, Shurie HHM, Shalabi AGA, et al. An outbreak of CrimeanCongo hemorrhagic fever in the United Arab Emirates. Am J Trop Med. Hyg. 1997; 57: 519-25.
https://doi.org/10.4269/ajtmh.....
30.
Watts DM, Flick R, Peters CJ, Shope RE. Bunyaviral fevers: Rift valley fever and Crimean-Congo hemorrhagic fever. In: Guerrant RL, Walker DH, Weller PF., editors. Tropical infectious diseases, principles, pathogens & practice. 2nd edition. Philadelphia: Churchill Livingdtone Elsevier; 2006. p. 756-760.
https://doi.org/10.1016/ B978-0-443-06668-9.50072-7.
31.
Kuthyar S, Anthony CL, Fashina T, Yeh S, Shantha JG. World Health Organization high priority pathogens: ophthalmic disease findings and vision health perspectives. Pathogens. 2021; 10(4): 442.
https://doi.org/10.3390/pathog....
32.
Mostafavi E, Ghasemian A, Abdinasir A, Nematollahi Mahani SA, Rawaf S, Salehi Vaziri M, et al. Emerging and re-emerging infectious diseases in the WHO Eastern Mediterranean region, 2001-2018. Int J Health Policy Manag. Epub 2021 Mar 6.
https://doi.org/10.34172/ijhpm....
34.
Peters JC, Mills JN, Spiropoulou C, Zaki SR, Rollin PE. Hantavirus infections. In: Guerrant RL, Walker DH, Weller PF., editors. Tropical infectious diseases. Principles, pathogens & practice. 2nd edition. Philadelphia: Churchill Livingstone Elsevier; 2006. p. 762-776.
https://doi.org/10.1016/B978-0....
35.
Schmaijohn C, Hjelle B. Hantavirus: aglobal disease problem. EID. 1997; 3(2): 95-104.
https://doi.org/10.3201/ eid0302.970202.
36.
Peters CJ, Simson GL, Levy H. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med. 1999; 50: 531-545.
https://doi.org/10.1146/annure.... med.50.1.531.
37.
Raftery MJ, Kraus AA, Ulrich R, Krüger DH, Schönrich G. Hantavirus infection of dendritic cells. J Virol. 2002; 76(21): 10724-10733.
https://doi.org/10.1128/JVI.76....
38.
Geimonen E, Neff S, Raymond T, Kocer SC, Gavrilovskaya IN, Mackow ER, et al. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell resposes. Proc. Natl Acad Sci USA. 2002; 99(21): 13837- 13842.
https://doi.org/10.1073/pnas.1....
39.
Gavrilovskaya IN, Peresleni T, Geimonen E, Mackow ER. Pathogenic hantaviruses selectively inhibit β3 integrin directed endothelial cell migration. Arch Virol. 2002; 147(10): 1913-1931.
https://doi.org/10.1007/ s00705-002-0852-0.
40.
Mandell GL, Bennett SE, Dolin R. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Virus Res. 2011; 162: 138-147.
42.
Korzeniewski K. [Medicine in travel]. Warszawa: e-PAGINA; 2012. p. 119-139 (in Polish).
43.
Pittalis S, Fusco FM, Lanini S, Nisii C, Puro V, Lauria FN, et al. Case definition for Ebola and Marburg haemorrhagic fevers: a compelx challange for epidemiologists and clinicians. New Microbiol. 2009; 32: 359- 367.
44.
Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011; 377: 849-862.
https://doi.org/10.1016/ S0140-6736(10)60667-8.
46.
Iwamura T, Guzman-Holst A, Murray KA. Accelerating invasion potential of disease vector Aedes aegypti under climate change. Nat Commun. 2020; 11: 2130.
https://doi.org/10.1038/s41467....